American Healthcare REIT, Inc (AHR) PT Raised to $53 at Truist Securities

Truist Securities analyst Michael Lewis raised the price target on American Healthcare REIT, Inc (NYSE: AHR) to $53.00 (from $46.00) while maintaining a Buy rating.

The analyst commented: "We are again raising our FFO estimates and price target following strong results and higher earnings guidance. We believe AHR appears very well positioned to benefit from favorable industry trends. We expect AHR to produce the strongest earnings growth in our coverage universe over the next few years, supporting a competitive PEG ratio, and believe our projections could prove conservative given the company’s investment pipeline and cost of equity. We are keeping our price target relatively conservative ($53), based on the calculation in Figure 2, and think risks are weighted to the upside."

You May Also Be Interested In

• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Cantor Fitzgerald Reiterates Overweight Rating on Applied Materials (AMAT)
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c